The number of people with diabetes in the world has risen to over 500 million. Diabetes is a major cause of blindness, kidney failure, heart attacks, stroke and lower limb amputation. WHO projects that diabetes will be the 7th leading cause of death in 2030.

You can manage diseases with regular use of PEMF therapy.


Within every three minutes there is another person being diagnosed with diabetes. This explains why we all know someone with diabetes.
Diabetes can come in one of two forms. The first is type one diabetes which is diagnosed in children. And the second is type two diabetes which is diagnosed in adults, but the age of onset is decreasing because of poor diet and genetic anticipation. No matter which type of diabetes you have, it can come with complications. These include, but are not limited to: chronic kidney disease, foot problems, non-traumatic lower limb (leg, foot, toe, etc.) amputation, eye disease (retinopathy) that can lead to blindness, heart attack, stroke, anxiety, nerve damage, and erectile dysfunction (men). Some of these complications are even life threatening. Currently, over 250,00 people in the united states undergo leg amputations from diabetic complications. PEMF therapy has saved diabetic patients from doctor recommended limb amputations in the past.

PEMF and Diabetes

PEMF therapy can be both preventative and curative for diabetic complications. One randomized clinical trial study suggests PEMF’s help diabetics by decreasing endoneural hypoxia, perineural edema, ischemia of peripheral nerves, and improving microcirculation that leads to positive changes after treatment sessions. The study goes on to say it can be concluded that the available data (from the study) provides the evidence that PEMF treatment has the potential to decrease neuropathic pain and nerve impulse permanently.

Another study conducted in Russia was focused on just vascular complications that come with diabetes. The study showed 74% of diabetics achieving positive results and only 28% in the control group achieving the same results.

A medical school in the United states conducted a study for the effects of PEMF’s on diabetic neuropathy. The study found that the sensations of pain, numbness, itching and tingling subsided after exposure to PEMF’s

There have been numerous other tests performed over the years showing the positive effects of PEMF’s on other diabetic complications as well. A few study results shown below:

  • PEMF can significantly accelerate healing in diabetics with purulent wound infections. Results of this study indicated that treatment with pulsating electromagnetic field either alone or in combination with laser therapy exhibited healing effects with respect to peripheral nerve lesions and general wound healing relative to controls.
  • The effect of PEMF on pressure ulcers has been studied on 20 elderly patients, hospitalized and bearing long-standing pressure ulcers. All were subjected to PEMF 1 -2 times daily parallel to conventional treatment. 5 control group patients underwent only conventional therapy, 5 others conventional + placebo PEMF treatment. After 2-weeks treatment, bulge healing rate was as follows: under PEMF 85% excellent and 15% very good healing; in the placebo group, 80% no improvement and 20% poor improvement; in the control group, 60% no improvement and 40% poor improvement. PEMF is strongly advised as a modern, noninvasive therapy of great efficiency.
  • A randomized, double blind, placebo-controlled multi-center study assessed the clinical efficacy and safety of PEMF in the healing of recalcitrant, predominantly venous leg ulcers. For 8 weeks, a portable device was used at home for 3 h daily as an adjunct to a wound dressing. Wound surface area, ulcer depth and pain intensity were assessed. 50% of the ulcers in the active group healed or markedly improved vs. 0% in the placebo group. 0% of the active group worsened vs. 54% of the placebo group (P < 0.001). PEMF is a safe and effective adjunct to non-surgical therapy for leg ulcers.
  • Double blind study on the effect of PEMF on the healing of skin ulcers. 44 patients; one-half exposed to active stimulators and the remaining to dummy stimulators (control group). The PEMF therapy lasted 90 days. The success rate in the experimental group was significantly higher after 90 days (p less than 0.02) and in the follow-up period (p less than 0.005). The data suggest that the effect of PEMF lasts even when the stimulation is over. No ulcers worsened in the experimental group, while four worsened in the control group. It is concluded that stimulation with PEMF is a useful adjunctive therapy.


Evaluation of the efficacy of pulsed electromagnetic field in the management of patients with diabetic polyneuropathy. Int J Diabetes Dev Ctries. 2009 Apr-Jun; 29(2): 56–61. Vinay Graak, Sarika Chaudhary, B. S. Bal,1 and J. S. Sandhu

I.B. Kirillov et al.: ‘Magnetotherapy in the Comprehensive Treatment of Vascular Complications of Diabetes Mellitus,’ Klin Med, 74 (5), 1996, pp. 39-41

Lau et al.: ‘Effect of Low Frequency Low Intensity Electromagnetic Field on Diabetic Neuropathy,’ Dept. of Microbiology, School of Medicine, Loma Linda University, USA. Scientific Report

R.A. Kuliev, R.F. Babaev: ‘PEMF combined with conventional treatment of suppurative Wounds in Diabetes Mellitus,’ Vestn Khir Im I I Grek, 148 (1), January 1992, pp. 33-36

A.V. Alekseenko et al.: ‘Use of PEMF Combined with Galvanization and Tissue Electrophoresis in the Treatment of Trophic Ulcers,’ Klein Khir (7-8), 1993, pp. 31-34

Comorosan S, Vasilco R, Arghiropol M, Paslaru L, Jieanu V, Stelea Fundeni Hospital, Bucharest, Romania. Romania Journal of Physiol., 30 (1-2), 1993, pp. 41-45

Stiller, Pak, Shupack, Thaler, Kenny, Jondreau; NY University Medical Centre, British Journal of Dermatology, 127 (2), 1992
Ieran, Zaffuto, Bagnacani, Annovi, Moratti, Cadossi; Medical Angiology, Reggio Emilia, Italy. Double blind study on the effect of PEMF on the healing of skin ulcers